The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with untreated advanced gastrointestinal stromal tumor (GIST).
 
Ping Chi
Consulting or Advisory Role - Deciphera; Exelixis; Merck (I)
Research Funding - Array BioPharma (Inst); Deciphera (Inst)
 
Li-Xuan Qin
Employment - MedImmune (I); Viela Bio (I)
Leadership - Viela Bio (I)
Stock and Other Ownership Interests - Viela Bio (I)
 
Ciara Marie Kelly
Research Funding - AGIOS (Inst); Amgen (Inst); Exicure (Inst); INCYTE (Inst); Kartos Therapeutics (Inst); Merck (Inst)
 
Sandra P. D'Angelo
Consulting or Advisory Role - Adaptimmune; Amgen; EMD Serono; GlaxoSmithKline; Immune design; Incyte; Merck; Nektar
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Deciphera (Inst); EMD Serono (Inst); Incyte (Inst); Merck (Inst); Nektar (Inst)
Travel, Accommodations, Expenses - Adaptimmune; EMD Serono; Nektar
 
Mark Andrew Dickson
Consulting or Advisory Role - Celgene
Research Funding - AADi (Inst); Lilly (Inst)
 
Mrinal M. Gounder
Honoraria - Bayer; Flatiron Health; Medscape; PER
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Daiichi Sankyo; Epizyme; Karyopharm Therapeutics; Springworks Therapeutics
Speakers' Bureau - Amgen
Patents, Royalties, Other Intellectual Property - UpToDate
Travel, Accommodations, Expenses - Epizyme
Other Relationship - Desmoid Tumor Research Foundation
(OPTIONAL) Uncompensated Relationships - Foundation Medicine
 
Mary Louise Keohan
No Relationships to Disclose
 
Sujana Movva
Consulting or Advisory Role - Genmab
Research Funding - Novartis (Inst); Takeda (Inst)
 
Benjamin Nacev
(OPTIONAL) Uncompensated Relationships - Delfi Diagnostics; Rapafusyn Pharmaceuticals
 
Aimee Marie Crago
Consulting or Advisory Role - Springworks Therapeutics
Patents, Royalties, Other Intellectual Property - Patent assigned to MSKCC for a companion diagnostic to CDK4 inhibitors - Patent number 9,889,135 (Inst)
 
Sam S. Yoon
Stock and Other Ownership Interests - Attis Lab
 
Gary A. Ulaner
Consulting or Advisory Role - Sanofi
Speakers' Bureau - Sanofi
Research Funding - Genentech; Puma Biotechnology; Sanofi
Patents, Royalties, Other Intellectual Property - GE Healthcare; Genentech; Novartis; Sanofi
 
Moriah Martindale
No Relationships to Disclose
 
Mercedes M. Condy
No Relationships to Disclose
 
Haley Phelan
Travel, Accommodations, Expenses - SpringWorks Therapeutics
 
Matthew Biniakewitz
No Relationships to Disclose
 
Samuel Singer
No Relationships to Disclose
 
Sinchun Hwang
No Relationships to Disclose
 
Cristina R. Antonescu
No Relationships to Disclose
 
William D. Tap
Leadership - Atropos; Certis Oncology Solutions
Stock and Other Ownership Interests - Atropos; Certis Oncology Solutions
Consulting or Advisory Role - Agios; Blueprint Medicines; Daiichi Sankyo; Deciphera; Eisai; EMD Serono; GlaxoSmithKline; Lilly; NanoCarrier
Research Funding - BioAtla; Blueprint Medicines; Daiichi Sankyo; Deciphera; Immune Design; Lilly; Novartis; Plexxikon; TRACON Pharma
Patents, Royalties, Other Intellectual Property - Companion Diagnostic for CDK4 inhibitors - 14/854,329